Complications after cardiac implantable electronic device implantations: An analysis of a complete, nationwide cohort in Denmark

European Heart Journal

Volumn 35, Issue 18, 2014, Pages 1186-1194

  Kirkfeldt, Rikke Esberg ^a,b   Johansen, Jens Brock ^b   Nohr, Ellen Aagaard ^c   Jorgensen, Ole Dan ^b   Nielsen, Jens Cosedis ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Cardiac resynchronization therapy; Complication; Implantable cardioverter defibrillator; Pacemaker; Predictors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIAC PERFORATION; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR THERAPEUTIC DEVICE; CHILD; COHORT ANALYSIS; DEFIBRILLATOR; DENMARK; DEVICE INFECTION; DUAL CHAMBER ICD; DUAL CHAMBER PACEMAKER; ELECTRICAL EQUIPMENT; EMERGENCY SURGERY; ENDOCARDITIS; FEMALE; HEART INJURY; HEMATOMA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEAD DISLODGEMENT; LEFT VENTRICULAR LEAD COMPLICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; OPERATOR; PERFORATION; PNEUMOTHORAX; POPULATION RESEARCH; PRIORITY JOURNAL; REOPERATION; RIGHT VENTRICULAR LEAD COMPLICATION; SEX DIFFERENCE; SINGLE CHAMBER ICD; SINGLE CHAMBER PACEMAKER; SURGICAL RISK; SYSTEMIC DISEASE; UNDERWEIGHT; WOUND INFECTION; AGE DISTRIBUTION; ARTIFICIAL HEART PACEMAKER; DEVICE REMOVAL; EPIDEMIOLOGY; INFANT; MIDDLE AGED; NEWBORN; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; PROSTHESIS FAILURE; RISK FACTOR; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DENMARK; DEVICE REMOVAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84900324755     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht511     Document Type: Article

References (34)

1. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol 2008;31: 1202-1212.
2. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM, 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329.
3. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006;47:2493-2497.
4. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The Relation Between Patients' Outcomesand the VolumeofCardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. J Am Coll Cardiol 2005;46:1536-1540.
5. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 2010;170:631-637.
6. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010;55:774-782.
7. Ellenbogen KA, Hellkamp AS, Wilkoff BL, Camunas JL, Love JC, Hadjis TA, Lee KL, Lamas GA. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003;92:740-741.
8. van Eck JW, van Hemel NM, Zuithof P, van Asseldonk JP, Voskuil TL, Grobbee DE, Moons KG. Incidence and predictors of in-hospital events after first implantation of pacemakers. Europace 2007;9:884-889.
9. Tobin K, Stewart J, Westveer D, Frumin H. Acute complicationsof permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol 2000;85:774-776.
10. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009;11:297-302.
11. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009;119: 1078-1084.
12. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.JAmCollCardiol 2011;58:1007-1013.
13. Nowak B, Misselwitz B, Erdogan A, Funck R, Irnich W, Israel CW, Olbrich HG, Schmidt H, Sperzel J, Zegelman M. Do gender differences exist in pacemaker im-plantation?-results of an obligatory external quality control program. Europace 2010;12:210-215.
14. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-998.
15. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner SM, Baddour LM. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-173.
16. World Health Organisation Technical Report Services. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. 2000.
17. Annual Statistics Report. Swedish ICD and Pacemaker Register. https://www.pacemakerregistret.se. Last accessed (13 February 2013).
18. Jahresbericht 2010 des Deutschen herzschrittmacher-und defibrillator-registers. http://www.pacemaker-register.de. Last accessed (13 February 2013).
19. Eberhardt F, Bode F, Bonnemeier H, Boguschewski F, Schlei M, Peters W, Wiegand UK. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart 2005;91:500-506.
20. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The relation between hospital procedure volume and complications of cardioverter- defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2010; 56:1133-1139.
21. MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P, Birnie D, Simpson CS, Khaykin Y, Pinter A, Nanthakumar K, Calzavara AJ, Austin PC, Tu JV, Lee DS. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med 2012;156:195-203.
22. Al-Khatib SM, Greiner MA, Peterson ED, Hernandez AF, Schulman KA, Curtis LH. Patient and implantingphysician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol 2008;1:240-249.
23. Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, Moons KG. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 2012;9:728-735.
24. Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Predictors of short-term complications after implantable cardioverter- defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol 2011;4: 136-142.
25. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 2010;122:1553-1561.
26. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28, 860 Danish patients. Heart Rhythm 2011;8:1622-1628.
27. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Pneumothorax in cardiac pacing: a population-based cohort study of 28 860 Danish patients. Euro-pace 2012;14:1132-1138.
28. Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. Physician procedure volume and complications of cardioverter-defibrillator implantation. Circulation 2012;125:57-64.
29. Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L. Lead complications, device infections, and clinical outcomes in thefirst year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchroniza-tion therapy-pacemaker. Europace 2013;15:71-76.
30. Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, Healey JS. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol 2012;35:131-134.
31. Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA. Influence ofage on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 2011;4:549-556.
32. Hsu JC, Varosy PD, Bao H, Wang Y, Curtis JP, Marcus GM. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the national cardiovascular data registry. J Am Heart Assoc 2012;1:e003863.
33. Curtis JP, Luebbert JJ, Wang Y, Rathore SS, Chen J, Heidenreich PA, Hammill SC, Lampert RI, Krumholz HM. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA 2009; 301:1661-1670.
34. Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q. Lead-and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141: 92-98.